glycerin 0.2 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Abreva Rapid Pain Relief]
RxNorm concept 2637875, branded drug (sbd). Prescribable name: Abreva Rapid Pain Relief 20 % / 4 % Topical Gel.
- RxCUI
- 2637875
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2637875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Abreva Rapid Pain Relief (glycerin 20 % / lidocaine hydrochloride 4 % ) Topical Gel
Related concepts
- glycerin 0.2 MG/MG (SCDC, consists of)
- lidocaine hydrochloride 0.04 MG/MG (SCDC, consists of)
- glycerin 0.2 MG/MG / lidocaine hydrochloride 0.04 MG/MG [Abreva Rapid Pain Relief] (SBDC, consists of)
- Topical Gel (DF, has dose form)
- Abreva Rapid Pain Relief (BN, has ingredient)
- glycerin 0.2 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel (SCD, tradename of)
Linked data
NDCs
- 00135040001
- 00766307278
- 00766307457
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2637875 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2637875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2637875. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.